Registered entities
Grey Wolf Therapeutics Limited
Reg. No. 10989365United Kingdom
Innovation
6 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 515 times.
| Year | Filings |
|---|---|
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 1 |
Investor mix
10 investors on record; lead investors include Pfizer, Earlybird, Andera Partners, Canaan.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 50% |
| Private equity | 1 | 10% |
| Bank & private debt | 1 | 10% |
| Other / undisclosed | 3 | 30% |